Becton Dickinson Earnings
NYSE: BDXHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 1:33 PM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$4.06
Becton Dickinson earnings summary
Becton Dickinson is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $4.06. In its most recent report on Aug 6, 2026 (Q3 2026), BDX posted EPS of $1.37. Revenue for the quarter was $4.98 billion.
Quarterly EPS is down 31.5% from the same quarter a year earlier. Across the last 16 reports, BDX shares moved an average of 2.2% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
BDX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $1.37 | — | +3.7% |
| May 7, 2026 | — | $-1.11 | — | -4.0% |
| Feb 9, 2026 | — | $1.34 | — | +5.4% |
| Nov 25, 2025 | — | $1.71 | — | -0.0% |
| Aug 7, 2025 | — | $2.00 | — | +1.3% |
| May 1, 2025 | — | $1.07 | — | -0.9% |
| Feb 6, 2025 | — | $1.04 | — | -2.2% |
| Nov 27, 2024 | — | $1.37 | — | -0.8% |
| Aug 1, 2024 | — | $1.68 | — | -2.5% |
| May 2, 2024 | — | $1.85 | — | +0.4% |
| Feb 1, 2024 | — | $0.96 | — | +2.8% |
| Nov 21, 2023 | — | $0.35 | — | -0.3% |
| Aug 3, 2023 | — | $1.36 | — | +4.3% |
| May 4, 2023 | — | $1.53 | — | -0.5% |
| Feb 2, 2023 | — | $1.70 | — | +0.8% |
| Nov 22, 2022 | — | $0.92 | — | +6.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.